Document is current
Any future updates will be listed below
-
Authors
Fujii, Ronaldo
Nouri, Masoud
Khan, Mohammad
Fleisinger, Lucija
Pugh, Jamie
Male, Gary
Panayi, Antonia https://orcid.org/0000-0002-1997-3705
-
Funding
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
- License Information
-
More Information
Article History
Accepted: 18 June 2026
First Online: 10 August 2026
Declarations
Conflicts of Interest: Ronaldo Fujii, Masoud Nouri, Mohammad Khan and Antonia Panayi are employees of Takeda Development Center Americas, Inc. and report holding stock and stock options in this company. Jamie Pugh and Gary Male are employees of Oxford PharmaGenesis Ltd. Lucija Fleisinger was an employee of Oxford PharmaGenesis Ltd at the time of manuscript development and review.
Author Contributions: All authors contributed to the outline and subsequent drafts of this manuscript. All authors contributed to the drafting and critical review of the manuscript content and approved the final manuscript.
Ethics Approval: Not applicable.
Consent to Participate: Not applicable.
Consent for Publication: Not applicable.
Availability of Data and Material: No data were generated or analyzed during development of this review. All information supporting this review is derived from previously published studies and their respective sources.
Code Availability: Not applicable.
